Описание
Carbamazepine may reduce levodopa efficacy through enzyme induction and pharmacodynamic antagonism, potentially worsening Parkinson's disease control.
Механизм
Carbamazepine induces hepatic enzymes that metabolize levodopa's carbidopa component, potentially increasing peripheral levodopa breakdown; it may also block dopaminergic effects centrally.
Клиническое значение
Worsening motor function has been reported in Parkinson's patients starting carbamazepine; tremor and rigidity may increase.
Тактика ведения
Monitor motor function closely; levodopa dose increase may be needed; consider alternative anticonvulsants (lamotrigine, gabapentin).
Медицинский отказ от ответственности
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.